1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Table 3:Number of CEMRI scans, total gadolinium doses, and commercial agents one-by-one in the group with HDN and NDN with doses collapsed
Contrast Medium NDN (n = 57) HDN (n = 80) No. of CEMRIs (p25 to p75) (median) 2.0 (1.0–5.0), 57 5.0 (2.0–8.0), 80 Total gadolinium (p25 to p75) (median) 40.0 (20.0–83.0), 57 76.0 (31.5–120.0), 80 Magnevist 51 (89.5) 62 (77.5) Any non-Magnevist agent used No 51 (89.5) 62 (77.5) Yes 6 (10.5) 18 (22.5) Omniscan No 53 (93.0) 70 (87.5) Yes 4 (7.0) 10 (12.5) MultiHance No 53 (93.0) 75 (93.8) Yes 4 (7.0) 5 (6.3) ProHance No 57 (100.0) 78 (97.5) Yes 0 (0.0) 2 (2.5) OptiMARK No 57 (100.0) 79 (98.8) Yes 0 (0.0) 1 (1.3) Gadavist No 57 (100.0) 79 (98.8) Yes 0 (0.0) 1 (1.3)